In a phase 2, randomized, double-blind, placebo-controlled study by Xu et al., doxycycline significantly reduced sputum MMP-9 levels, improved lung function, and increased time to next exacerbation in CF patients during acute pulmonary exacerbations [62]. This evidence concerns the gene MMP9 and cystic fibrosis.